Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: Clinical implications for the nervous system response to glucocorticoids and stress

Molecular Endocrinology

Volumn 21, Issue 7, 2007, Pages 1552-1568

  Kino, Tomoshige ^a   Ichijo, Takamasa ^a   Amin, Niranjana D ^b   Kesavapany, Sashi ^b   Wang, Yonghong ^c   Kim, Nancy ^a   Rao, Sandesh ^a   Player, Audrey ^c   Zheng, Ya Li ^b   Garabedian, Michael J ^d   Kawasaki, Ernest ^c   Pant, Harish C ^b   Chrousos, George P ^a,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; DNA; GLUCOCORTICOID RECEPTOR; PROTEIN P25; PROTEIN P35; SERINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA TRANSCRIPTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; MORPHOGENESIS; NERVOUS SYSTEM FUNCTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; STRESS;

ANIMALS; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE 5; DEXAMETHASONE; DNA PRIMERS; HUMANS; LIGANDS; MULTIPROTEIN COMPLEXES; NERVE TISSUE PROTEINS; NEURONS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; PURINES; RATS; RECEPTORS, GLUCOCORTICOID; RECOMBINANT PROTEINS; SERINE; STRESS; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

RATTUS;

EID: 34347255773     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0345     Document Type: Article

References (65)

1. Chrousos GP 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
2. Kino T, Chrousos GP 2005 Glucocorticoid effect on gene expression. In: Steckler T, Kalin NH, Reul JMHM, eds. Handbook on stress and the brain. Amsterdam: Elsevier BV; 295-312
3. Kino T, Chrousos GP 2004 Glucocorticoid and mineralocorticoid receptors and associated diseases. Essays Biochem 40:137-155
4. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
5. Rosenfeld MG, Lunyak VV, Glass CK 2006 Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405-1428
6. Kino T, Chrousos GP 2002 Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: multifactorial states of clinical importance. J Allergy Clin Immunol 109:609-613
7. Ismaili N, Garabedian MJ 2004 Modulation of glucocorticoid receptor function via phosphorylation. Ann NY Acad Sci 1024:86-101
8. Itoh M, Adachi M, Yasui H, Takekawa M, Tanaka H, Imai K 2002 Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol 16:2382-2392
9. Szatmary Z, Garabedian MJ, Vilcek J 2004 Inhibition of glucocorticoid receptor-mediated transcriptional activation by p38 mitogen-activated protein (MAP) kinase. J Biol Chem 279:43708-43715
10. Rogatsky I, Logan SK, Garabedian MJ 1998 Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc Natl Acad Sci USA 95:2050-2055
11. Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ 1997 Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 17:3947-3954
12. Wang Z, Frederick J, Garabedian MJ 2002 Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. J Biol Chem 277:26573-26580
13. Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M, Cidlowski JA 1997 Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J Biol Chem 272:9287-9293
14. Kesavapany S, Li BS, Pant HC 2003 Cyclin-dependent kinase 5 in neurofilament function and regulation. Neurosignals 12:252-264
15. Smith DS, Greer PL, Tsai LH 2001 Cdk5 on the brain. Cell Growth Differ 12:277-283
16. Dhavan R, Tsai LH 2001 A decade of CDK5. Nat Rev Mol Cell Biol 2:749-759
17. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB 1996 Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93:11173-11178
18. Tsai LH, Delalle I, Caviness Jr VS, Chae T, Harlow E 1994 p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419-423
19. Tang D, Wang JH 1996 Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators. Prog Cell Cycle Res 2:205-216
20. Julien JP, Mushynski WE 1998 Neurofilaments in health and disease. Prog Nucleic Acid Res Mol Biol 61:1-23
21. Lau LF, Seymour PA, Sanner MA, Schachter JB 2002 Cdk5 as a drug target for the treatment of Alzheimer's disease. J Mol Neurosci 19:267-273
22. Lee KY, Clark AW, Rosales JL, Chapman K, Fung T, Johnston RN 1999 Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 34:21-29
23. Ahlijanian MK, Barrezueta NX, Williams RD, Jakowski A, Kowsz KP, McCarthy S, Coskran T, Carlo A, Seymour PA, Burkhardt JE, Nelson RB, McNeish JD 2000 Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci USA 97:2910-2915
24. Nguyen MD, Lariviere RC, Julien JP 2001 Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 30:135-147
25. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH 2003 Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40:471-483
26. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH 2000 Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364
27. Kusakawa G, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga S 2000 Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem 275:17166-17172
28. Amin ND, Albers W, Pant HC 2002 Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J Neurosci Res 67:354-362
29. Tsai KJ, Chen SK, Ma YL, Hsu WL, Lee EH 2002 sgk, A primary glucocorticoid-induced gene, facilitates memory consolidation of spatial learning in rats. Proc Natl Acad Sci USA 99:3990-3995
30. Yang YC, Lin CH, Lee EH 2006 Serum- and glucocorticoid-inducible kinase 1 (SGK1) increases neurite formation through microtubule depolymerization by SGK1 and by SGK1 phosphorylation of τ. Mol Cell Biol 26:8357-8370
31. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL 1993 Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13:2031-2040
32. Itani OA, Liu KZ, Cornish KL, Campbell JR, Thomas CP 2002 Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5′-flanking region. Am J Physiol Endocrinol Metab 283:E971-E979
33. Veeranna, Shetty KT, Link WT, Jaffe H, Wang J, Pant HC 1995 Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J Neurochem 64:2681-2690
34. Songyang Z, Lu KP, Kwon YT, Tsai LH, Filhol O, Cochet C, Brickey DA, Soderling TR, Bartleson C, Graves DJ, DeMaggio AJ, Hoekstra MF, Blenis J, Hunter T, Cantley LC 1996 A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol Cell Biol 16:6486-6493
35. Beaudette KN, Lew J, Wang JH 1993 Substrate specificity characterization of a cdc2-like protein kinase purified from bovine brain. J Biol Chem 268:20825-20830
36. Orti E, Hu LM, Munck A 1993 Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors. J Biol Chem 268:7779-7784
37. Moreno S, Nurse P 1990 Substrates for p34cdc2: in vivo veritas? Cell 61:549-551
38. Ichijo T, Voutetakis A, Cotrim AP, Bhattachryya N, Fujii M, Chrousos GP, Kino T 2005 The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications. J Biol Chem 280:42067-42077
39. Chrousos GP, Kino T 2005 Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci STKE 2005:pe48
40. Muchardt C, Yaniv M 1999 The mammalian SWI/SNF complex and the control of cell growth. Semin Cell Dev Biol 10:189-195
41. Cheung ZH, Fu AK, Ip NY 2006 Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron 50:13-18
42. Nikolic M 2004 The molecular mystery of neuronal migration: FAK and Cdk5. Trends Cell Biol 14:1-5
43. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH 1997 Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18:29-42
44. Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, Mount MP, O'Hare MJ, Callaghan S, Slack RS, Przedborski S, Anisman H, Park DS 2003 Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 100:13650-13655
45. Bu B, Li J, Davies P, Vincent I 2002 Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J Neurosci 22:6515-6525
46. Wolkowitz OM 1994 Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 19:233-255
47. Hochberg Z, Pacak K, Chrousos GP 2003 Endocrine withdrawal syndromes. Endocr Rev 24:523-538
48. Oitzl MS, de Kloet ER, Joels M, Schmid W, Cole TJ 1997 Spatial learning deficits in mice with a targeted glucocorticoid receptor gene disruption. Eur J Neurosci 9:2284-2296
49. Boyle MP, Brewer JA, Funatsu M, Wozniak DF, Tsien JZ, Izumi Y, Muglia LJ 2005 Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci USA 102:473-478
50. Prickaerts J, Steckler T 2005 Effects of glucocortiocids on emotion and cognitive process in animals. In: Steckler T, Kalin NH, Reul JMHM, eds. Handbook of stress and the brain. Amsterdam: Elsevier B.V.; 359-385
51. Lupien SJ, Maheu FS, Weeks N 2005 Glucocorticid effects on human cognition. In: Steckler T, Kalin NH, Reul JMHM, eds. Handbook of stress and the brain. Amsterdam: Elsevier B.V.; 387-402
52. Holsboer F, Barden N 1996 Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocr Rev 17:187-205
53. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH 1999 Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-622
54. Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB 2005 p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19:1569-1583
55. Ismaili N, Blind R, Garabedian MJ 2005 Stabilization of the unliganded glucocorticoid receptor by TSG101. J Biol Chem 280:11120-11126
56. Lu NZ, Cidlowski JA 2005 Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18:331-342
57. Sun Z, Pan J, Hope WX, Cohen SN, Balk SP 1999 Tumor susceptibility gene 101 protein represses androgen receptor transactivation and interacts with p300. Cancer 86:689-696
58. Chrousos GP 2001 Glucocorticoid therapy. In: Felig P, Frohman LA, eds. Endocrinology and metabolism. 4th ed. New York: McGraw-Hill; 609-632
59. Charmandari E, Chrousos GP, Ichijo T, Bhattacharyya N, Vottero A, Souvatzoglou E, Kino T 2005 The human glucocorticoid receptor (hGR) β isoform suppresses the transcriptional activity of hGRα by interfering with formation of active coactivator complexes. Mol Endocrinol 19:52-64
60. Kesavapany S, Amin N, Zheng YL, Nijhara R, Jaffe H, Sihag R, Gutkind JS, Takahashi S, Kulkarni A, Grant P, Pant HC 2004 p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (Ras-GRF2) mediates Rac-dependent extracellular signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons. J Neurosci 24:4421-4431
61. De Martino MU, Bhattachryya N, Alesci S, Ichijo T, Chrousos GP, Kino T 2004 The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism. Mol Endocrinol 18:820-833
62. Kino T, Tiulpakov A, Ichijo T, Chheng L, Kozasa T, Chrousos GP 2005 G protein β interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J Cell Biol 169:885-896
63. Kino T, Gragerov A, Kopp JB, Stauber RH, Pavlakis GN, Chrousos GP 1999 The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J Exp Med 189:51-62
64. Tarricone C, Dhavan R, Peng J, Areces LB, Tsai LH, Musacchio A 2001 Structure and regulation of the CDK5-p25(nck5a) complex. Mol Cell 8:657-669
65. Mapelli M, Musacchio A 2003 The structural perspective on CDK5. Neurosignals 12:164-172